4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001104659-21-140230
Director acquired 100,000 shares (conversion)
- Director returned 14,887 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BARASCH RICHARD A Director | 2021-11-12 | Conversion | +100,000 | 100,000 | D: show line 1 in the form | ||
| BARASCH RICHARD A Director | 2021-11-12 | Returned to the company | −14,887 | 85,113 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BARASCH RICHARD A Director | 2021-11-12 | Conversion · Class B Common Stock | −100,000 | 0 | D: show line 3 in the form |
Loading xslF345X03/tm2132979-16_4seq1.xml…